Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04864314Not ApplicableCompleted

Assessment of TetraSOD® Efficacy to Improve Semen Parameters in Men With Idiopathic Infertility

Role: collaborator

NCT04935840Not ApplicableActive Not Recruiting

Evaluation of the Effect of FertyBiotic Pregnancy in the Metabolic Profile in Pregnant Women

Role: lead

NCT05176535Not ApplicableCompleted

Determination of Vaginal Colonization and the Effect of an Oral Probiotic (PROSALVAG)

Role: lead

NCT04670393Not ApplicableCompleted

Antioxidant Supplement Associated With Oral Probiotics in Patients With PCOS in IVF

Role: lead

NCT06324071Not ApplicableRecruiting

Study to Verify the Efficacy of a Product Containing 125 mg of TetraSOD® for the Treatment of Male Infertility

Role: collaborator

All 5 trials loaded